ELANCO ANIMAL HEALTH INC (ELAN) Stock Analyst Ratings
NYSE:ELAN • US28414H1032
24.75 USD
-0.23 (-0.92%)
At close: Feb 23, 2026
25.0885 USD
+0.34 (+1.37%)
After Hours: 2/23/2026, 8:04:00 PM
ChartMill assigns a Buy % Consensus number of 85% to ELAN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 26.99. This target is 9.05% above the current price.
- ELAN was analyzed by 22 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ELAN.
- In the previous month the buy percentage consensus was at a similar level.
- ELAN was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-22 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-12-18 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-21 | Keybanc | Initiate | Overweight |
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-20 | UBS | Maintains | Buy -> Buy |
| 2025-10-07 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-09-24 | Stifel | Maintains | Buy -> Buy |
| 2025-08-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-07-23 | UBS | Maintains | Buy -> Buy |
| 2025-07-17 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-07-02 | Stifel | Maintains | Buy -> Buy |
| 2025-06-26 | William Blair | Upgrade | Market Perform -> Outperform |
| 2025-05-19 | Stifel | Maintains | Buy -> Buy |
| 2025-05-08 | Stifel | Maintains | Buy -> Buy |
| 2025-04-14 | Stifel | Maintains | Buy -> Buy |
| 2025-03-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-26 | UBS | Maintains | Buy -> Buy |
| 2025-02-26 | Stifel | Maintains | Buy -> Buy |
| 2025-02-26 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-21 | Stifel | Maintains | Buy -> Buy |
| 2025-01-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-07 | Stifel | Maintains | Buy -> Buy |
| 2024-12-09 | UBS | Initiate | Buy |
| 2024-12-02 | Leerink Partners | Initiate | Market Perform |
| 2024-11-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-28 | Barclays | Maintains | Overweight -> Overweight |
ELANCO ANIMAL HEALTH INC / ELAN FAQ
What is the average price target for ELANCO ANIMAL HEALTH INC (ELAN) stock?
22 analysts have analysed ELAN and the average price target is 26.99 USD. This implies a price increase of 9.05% is expected in the next year compared to the current price of 24.75.
How do analysts rate ELANCO ANIMAL HEALTH INC (ELAN)?
The consensus rating for ELANCO ANIMAL HEALTH INC (ELAN) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for ELANCO ANIMAL HEALTH INC stock?
The number of analysts covering ELANCO ANIMAL HEALTH INC (ELAN) is 22.